drugset / Trial / NCT00276263

Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia

NCT00276263

Phase 2 Withdrawn Herzog Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether preventative treatment with sarcosine can reduce symptoms and delay/avoid disease progression in individuals defined as being in a prodromal stage of schizophrenia.

Timeline

Start
2006-08
Primary completion
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Sarcosine Other / unclassified 2 g

Indications